{reportSlug=global-rare-disease-drug-market, reportId=29206, mktKeyword=Rare Disease Drug, cagr=0.00, publishDate=Apr 2024, priceOption2=7500, reportTitle=Rare Disease Drug Comprehensive Study by Type (Biologics, Non-Biologics), Application (Hospitals, Clinics, Others), Disease (Oncologic Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious Diseases, Neurologic Diseases, Other Rare Diseases), Form (Tablet, Powder, Injections, Others), Distribution Channel (Pharmacies, Grocery Stores, Internet Sales, Mail Order, Direct Marketing Routes, Other Convenience Stores), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=200, priceOption1=3750, forecastYr=2030, noOfPages=244, reportKey=28950, breadcrum=Global Rare Disease Drug}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Apr 2024 244 Pages 72 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner